Dale Umetsu

Dale Umetsu is currently a Scientific Advisor at IgGenix. Prior to this, they served as the Chief Development Officer at Pareto from February 2020 to August 2022. From January 2018 to December 2018, Dale served as the Vice President of Clinical Development at Dermira, Inc. overseeing clinical development projects for small molecules and biologics. From November 2013 to December 3018, Dale was a Principal Medical Director at Genentech where they led the Global Development Team for Xolair. Dale also has experience as a Professor at Harvard Medical School from January 2005 to December 2013.

Dale Umetsu has an MD and PhD from Harvard Medical School. Dale is also certified from the ACGME in Pediatrics and Allergy/Immunology.